Children's National Medical Center
- Advisory Board: Bristol-Myers Squibb; Eli Lilly and Company; Otsuka America Pharmaceutical, Inc.
- Consultant: Forest Laboratories, Inc.; Lundbeck
- Grant Support: Bristol-Myers Squibb; Forest Laboratories, Inc.; GlaxoSmithKline; Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; National Institute of Mental Health (NIMH); Pfizer Inc; Sepracor Inc.; Supernus
- Honorarium for participation in this meeting: American Academy of Child & Adolescent Psychiatry
- Research Support: National Institute of Child Health and Human Development (NICHD)
- Speakers Bureau: Bristol-Myers Squibb; Eli Lilly and Company; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
- Study preliminary site visit done, trial never started : Merck & Co., Inc.
- Travel Support to attend this meeting: Otsuka America Pharmaceutical, Inc.
- contract not grant: National Institute of Child Health and Human Development (NICHD)
- contributing editor to ADHD biweekly literature update: Epocrates